Abbott CEO ‘Hopeful’ Abbott said in July it may have to pull Similac for premature infants off shelves if ... s Similac formula and Reckitt’s Enfamil in a single case. The hospital where ...

Abbott said in July it may have to pull Similac for premature infants off shelves if juries continue to side ... allegations about both Abbott’s Similac formula and Reckitt’s Enfamil in a single case.

Reckitt saw sales surpass expectations in the third quarter as the consumer giant was boosted by healthcare brands, including Durex condoms and Nurofen.

A jury found Abbott Laboratories and Mead Johnson, owned by U.K.-based Reckitt Benckiser, not responsible for a young boy's intestinal disease, the result of a lawsuit that alleged the companies ...

Mead Johnson had already been ordered to pay $60m in damages in March to Jasmine Watson, the mother whose baby died after being fed the company’s Enfamil Premature 24 brand of formula.

This came after the company in March was ordered to pay $60 million in compensation related to the death of a premature baby that was fed its Enfamil Premature 24 product. Nearly 1,000 such ...

Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their ...

In the first case to go to trial in March, Reckitt Benckiser was ordered to pay $60 million in damages to a mother whose premature child died after consuming the company’s Enfamil baby formula.

Earlier this year, the firm suffered a blow when a court ruled in March that it would have to pay £46million ($60million) in ...

Between 2019 and 2023, the market grew at a CAGR of 9%, driven by the rising health-consciousness of consumers, particularly millennial and Gen-Z parents. As precision nutrition technologies advance, ...

Reckitt has also launched a strategic review of its troubled infant-formula unit Mead Johnson after it was ordered to pay a $60 million compensation in March related to the death of a premature ...